20-64074527-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005873.3(RGS19):c.167G>A(p.Arg56Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000365 in 1,562,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005873.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGS19 | ENST00000395042.2 | c.167G>A | p.Arg56Gln | missense_variant | 4/6 | 1 | NM_005873.3 | ENSP00000378483.1 | ||
RGS19 | ENST00000332298.9 | c.167G>A | p.Arg56Gln | missense_variant | 4/6 | 1 | ENSP00000333194.5 | |||
RGS19 | ENST00000493165.1 | n.753G>A | non_coding_transcript_exon_variant | 4/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152198Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.000283 AC: 47AN: 165850Hom.: 0 AF XY: 0.000348 AC XY: 31AN XY: 89080
GnomAD4 exome AF: 0.000379 AC: 534AN: 1410634Hom.: 0 Cov.: 34 AF XY: 0.000354 AC XY: 247AN XY: 697210
GnomAD4 genome AF: 0.000243 AC: 37AN: 152198Hom.: 0 Cov.: 34 AF XY: 0.000296 AC XY: 22AN XY: 74356
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2021 | The c.167G>A (p.R56Q) alteration is located in exon 4 (coding exon 3) of the RGS19 gene. This alteration results from a G to A substitution at nucleotide position 167, causing the arginine (R) at amino acid position 56 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at